|
1
|
Prado R, Francis SO, Mason MN, Wing G,
Gamble RG and Dellavalle R: Nonmelanoma skin cancer
chemoprevention. Dermatol Surg. 37:1566–1578. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Dréno B, Mansat E, Legoux B and Litoux P:
Skin cancer in transplant patients. Nephrol Dial Transplant.
13:1374–1379. 1998. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Rajan N, Ryan J and Langtry JA: Squamous
cell carcinoma arising within a facial port-wine stain treated by
mohs micrographic surgical excision. Dermatol Surg. 32:864–866.
2006. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Smith TJ, Ryan LM, Douglass HO Jr, Haller
DG, Dayal Y, Kirkwood J, Tormey DC, Schutt AJ, Hinson J and Sischy
B: Combined chemoradiotherapy vs. radiotherapy alone for early
stage squamous cell carcinoma of the esophagus: A study of the
Eastern Cooperative Oncology Group. Int J Radiat Oncol Biol Phys.
42:269–276. 1998. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Moreno G, Chia AL, Lim A and Shumack S:
Therapeutic options for Bowen's disease. Australas J Dermatol.
48:1–8; quiz 9–10. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Giuliano EA, Johnson PJ, Delgado C, Pearce
JW and Moore CP: Local photodynamic therapy delays recurrence of
equine periocular squamous cell carcinoma compared to cryotherapy.
Vet Ophthalmol. 17:(Suppl 1). S37–S45. 2014. View Article : Google Scholar
|
|
7
|
Canis M, Ihler F, Martin A, Matthias C and
Steiner W: Transoral laser microsurgery for T1a glottic cancer:
Review of 404 cases. Head Neck. 37:889–895. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Szeimies RM, Morton CA, Sidoroff A and
Braathen LR: Photodynamic therapy for non-melanoina skin cancer.
Acta Derm Venereol. 85:483–490. 2005.PubMed/NCBI
|
|
9
|
Shimizu I, Cruz A, Chang KH and Dufresne
RG: Treatment of squamous cell carcinoma in situ: A review.
Dermatol Surg. 37:1394–1411. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Fang J, Lu J and Holmgren A: Thioredoxin
reductase is irreversibly modified by curcumin: A novel molecular
mechanism for its anticancer activity. J Biol Chem.
280:52284–52290. 2005. View Article : Google Scholar
|
|
11
|
Jurenka JS: Anti-inflammatory properties
of curcumin, a major constituent of curcum longa: A review of
preclinical and clinical research. Altern Med Rev. 14:141–153.
2009.PubMed/NCBI
|
|
12
|
LoTempio MM, Veena MS, Steele HL,
Ramamurthy B, Ramalingam TS, Cohen AN, Chakrabarti R, Srivatsan ES
and Wang MB: Curcumin suppresses growth of head and neck squamous
cell carcinoma. Clin Cancer Res. 11:6994–7002. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Gupta SC, Patchva S, Koh W and Aggarwal
BB: Discovery of Curcumin, a component of golden spice, and its
miraculous biological activities. Clin Exp Pharmacol Physiol.
39:283–299. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Tamvakopoulos C, Dimas K, Sofianos ZD,
Hatziantoniou S, Han Z, Liu ZL, Wyche JH and Pantazis P: Metabolism
and anticancer activity of the curcumin analogue,
dimethoxycurcumin. Clin Cancer Res. 13:1269–1277. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Lin SS, Lai KC, Hsu SC, Yang JS, Kuo CL,
Lin JP, Ma YS, Wu CC and Chung JG: Curcumin inhibits the migration
and invasion of human A549 lung cancer cells through the inhibition
of matrix metalloproteinase-2 and-9 and vascular endothelial growth
factor (VEGF). Cancer Lett. 285:127–133. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Chen HW, Lee JY, Huang JY, Wang CC, Chen
WJ, Su SF, Huang CW, Ho CC, Chen JJ, Tsai MF, et al: Curcumin
inhibits lung cancer cell invasion and metastasis through the tumor
suppressor HLJ1. Cancer Res. 68:7428–7438. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Ni X, Zhang A, Zhao Z, Shen Y and Wang S:
Demethoxycurcumin inhibits cell proliferation, migration and
invasion in prostate cancer cells. Oncol Rep. 28:85–90.
2012.PubMed/NCBI
|
|
18
|
Schneider CA, Rasband WS and Eliceiri KW:
NIH Image to ImageJ: 25 years of image analysis. Nat Methods.
9:671–675. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Teiten MH, Gaascht F, Cronauer M, Henry E,
Dicato M and Diederich M: Anti-proliferative potential of curcumin
in androgen-dependent prostate cancer cells occurs through
modulation of the wingless signaling pathway. Int J Oncol.
38:603–611. 2011.PubMed/NCBI
|
|
20
|
Lee YK, Park SY, Kim Ym and Park OJ:
Regulatory effect of the AmPK-COX-2 signaling pathway in
curcumin-induced apoptosis in HT-29 colon cancer cells. Ann N Y
Acad Sci. 1171:489–494. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Yodkeeree S, Ampasavate C, Sung B,
Aggarwal BB and Limtrakul P: Demethoxycurcumin suppresses migration
and invasion of MDA-MB-231 human breast cancer cell line. Eur J
Pharmacol. 627:8–15. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Sharma RA, Steward WP and Gescher AJ:
Pharmacokinetics and pharmacodynamics of curcumin. Adv Exp Med
Biol. 595:453–470. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Ni X, Zhang A, Zhao Z, Shen Y and Wang S:
Demethoxycurcumin inhibits cell proliferation, migration and
invasion in prostate cancer cells. Oncol Rep. 28:85–90.
2012.PubMed/NCBI
|
|
24
|
Cheng CY, Lin YH and Su CC: Curcumin
inhibits the proliferation of human hepatocellular carcinoma J5
cells by inducing endoplasmic reticulum stress and mitochondrial
dysfunction. Int J Mol Med. 26:673–678. 2010.PubMed/NCBI
|
|
25
|
Luthra PM, Kumar R and Prakash A:
Demethoxycurcumin induces Bcl-2 mediated G2/M arrest and apoptosis
in human glioma U87 cells. Biochem Biophys Res Commun. 384:420–425.
2009. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Liang CZ, Zhang JK, Shi Z, Liu B, Shen CQ
and Tao HM: Matrine induces caspase-depedent apoptosis in human
osteosarcoma cells intro and in vivo through the upregulation of
Bax and Fas/FasL and downregulation of Bcl-2. Cancer Chemother
Pharmacol. 69:317–331. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Ghate NB, Hazra B, Sarkar R, Chaudhuri D
and Mandal N: Alteration of Bax/Bcl-2 ratio contributes to
Terminalia belerica-induced apoptosis in human lung and breast
carcinoma. In Vitro Cell Dev Biol Anim. 50:527–537. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Zeng H, Kong X, Peng H, Chen Y, Cai S, Luo
H and Chen P: Apoptosis and Bcl-2 family proteins, taken to chronic
obstructive pulmonary disease. Eur Rev Med Pharmacol Sci.
16:711–727. 2012.PubMed/NCBI
|
|
29
|
Cory S, Huang DC and Adams JM: The Bcl-2
family: Roles in cell survival and oncogenesis. Oncogene.
22:8590–8607. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Hilchie AL, Furlong SJ, Sutton K,
Richardson A, Robichaud MR, Giacomantonio CA, Ridgway ND and Hoskin
DW: Curcumin-induced apoptosis in PC3 prostate carcinoma cells is
caspase-independent and involves cellular ceramide accumulation and
damage to mitochondria. Nutr Cancer. 62:379–389. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Li Y, Zhang S, Geng JX and Hu XY: Curcumin
inhibits human non-small cell lung cancer A549 cell proliferation
through regulation of Bcl-2/Bax and cytochrome C. Asian Pac J
Cancer Prev. 14:4599–4602. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Cain K, Brmton SB, Langlais C, Walker G,
Brown DG, Sun XM and Cohen GM: Apaf-1 oligomerizes into
biologically active approximately 700-kDa and inactive
approximately 1.4-MDa apoptosome complexes. J Biol Chem.
275:6067–6070. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Balasubramanian S and Eckert RL: Curcumin
suppresses AP1 transcription factor-dependent differentiation and
activates apoptosis in human epidermal keratinocytes. J Biol Chem.
282:6707–6715. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Mazumder S, Plesea D and Almasan A:
Caspase-3 activation is acritical determinant of genotoxic
stress-induced apoptosis. Methods Mol Biol. 414:13–21.
2008.PubMed/NCBI
|
